
Jon A Kobashigawa MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation
Clinical Professor of Medicine, UCLA
Join to view full profile
127 S San Vicente Blvd# A3107Los Angeles, CA 90048
Phone+1 310-248-3830
Fax+1 310-248-8338
Dr. Kobashigawa is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1984 - 1986
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1980 - 1983
Icahn School of Medicine at Mount SinaiClass of 1980
Stanford UniversityB.S., 1972 - 1976
Certifications & Licensure
CA State Medical License 1981 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2012, 2014, 2016-2017
Clinical Trials
- A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)
- Home Electrocardiogram (ECG) Monitoring After Heart Transplantation
- Heartsbreath Test for Heart Transplant Rejection
Publications & Presentations
PubMed
- Donor diabetes status impacts long-term survival in diabetic heart transplant recipients.Brian Lim, Allen A Razavi, Aminah Sallam, Vikram Krishna, Federico Sertic
JHLT Open. 2026-11-01 - Ex Vivo Therapeutics in Cardiac Xenotransplantation: A Scoping Review.Duc M Giao, Pedro A Catarino, Dominic Emerson, Kambiz Ghafourian, Jon Kobashigawa
Xenotransplantation. 2026-10-10 - Heart Transplantation in 2076: Precision, Prevention, and Regeneration.Lily K Stern, Kelly Perkins, Jon A Kobashigawa
Journal of Cardiac Failure. 2026-09-01
Journal Articles
- Omission of Heart Transplant Recipients from the Appropriate Use Criteria for Revascularization and the Ramifications on Heart Transplant CentersJon A Kobashigawa, Steven W Tabak, Wendy Book, John A Spertus, JAMA Cardiology
- Non‐Invasive Detection of Graft Injury After Heart Transplantation Using Donor‐Derived Cell‐Free DNA: A Prospective Multi‐Center StudyGregory Ewald, Jon Kobashigawa, Kiran K Khush, Jignesh Patel, Eugene DePasquale, Sean Pinney, American Journal of Transplantation
- Oxford University Press Has Registered This DOI Pre-PublicationMichelle Kittleson, Heidi Reich, Lawrence Czer, Dominick Megna, Jignesh Patel, Fardad Esmailian, Jon Kobashigawa, Oxford University Press
Authored Content
- Omission of Heart Transplant Recipients from the Appropriate Use Criteria for Revascularization and the Ramifications on Heart Transplant CentersApril 2020
- Temporal Trends of De Novo Malignancy Development After Heart TransplantationJanuary 2018
- Temporal Trends of De Novo Malignancy Development After Heart TransplantationJanuary 2018
Press Mentions
Cedars-Sinai Sets New Record in Organ TransplantationFebruary 28th, 2025
Smidt Heart Institute Experts Available for Interviews During ISHLT ConferenceApril 18th, 2023
ISHLT Honors Jon Kobashigawa for Lifetime Achievement in Treating Advanced Heart DiseaseFebruary 15th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: